Cellens

Cellens develops non-invasive cancer diagnostic tests that utilize nanoscale biophysical profiling of cells found in urine samples. The company primarily targets the urology market, aiming to improve the accuracy of cancer detection and reduce the need for invasive procedures like cystoscopies.